Glioblastomas are composed of genetically divergent clones with distinct tumourigenic potential and variable stem cell-associated phenotypes

Glioblastoma (GBM) is known to be a heterogeneous disease; however, the genetic composition of the cells within a given tumour is only poorly explored. In the advent of personalised medicine the understanding of intra-tumoural heterogeneity at the cellular and the genetic level is mandatory to impro...

Descripción completa

Detalles Bibliográficos
Autores principales: Stieber, Daniel, Golebiewska, Anna, Evers, Lisa, Lenkiewicz, Elizabeth, Brons, Nicolaas H. C., Nicot, Nathalie, Oudin, Anaïs, Bougnaud, Sébastien, Hertel, Frank, Bjerkvig, Rolf, Vallar, Laurent, Barrett, Michael T., Niclou, Simone P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2013
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895194/
https://www.ncbi.nlm.nih.gov/pubmed/24154962
http://dx.doi.org/10.1007/s00401-013-1196-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895194/
https://www.ncbi.nlm.nih.gov/pubmed/24154962
http://dx.doi.org/10.1007/s00401-013-1196-4

Ejemplares similares